Related references
Note: Only part of the references are listed.Wrong intraocular lens implant; learning from reported patient safety incidents
S. P. Kelly et al.
EYE (2011)
META-ANALYSIS OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS Causative Organisms and Possible Prevention Strategies
Colin A. McCannel
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Patient safety incidents involving neuromuscular blockade: analysis of the UK National Reporting and Learning System data from 2006 to 2008
J. Arnot-Smith et al.
ANAESTHESIA (2010)
Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
Lesley H. Curtis et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study
Davin Johnson et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2010)
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review
Christine Schmucker et al.
CURRENT OPINION IN OPHTHALMOLOGY (2010)
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Pascale Massin et al.
DIABETES CARE (2010)
Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008
C. Bunce et al.
EYE (2010)
Why is patient safety so hard? A selective review of ethnographic studies
Mary Dixon-Woods
JOURNAL OF HEALTH SERVICES RESEARCH & POLICY (2010)
Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment
W. Amoaku
EYE (2009)
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting
Suman Pilu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection
John O. Mason et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
David R. Fintak et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Surgical confusions in ophthalmology
John W. Simon et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Quality of life in age-related macular degeneration: a review of the literature
Jan Mitchell et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Attitudes and barriers to incident reporting: a collaborative hospital study
SM Evans et al.
QUALITY & SAFETY IN HEALTH CARE (2006)
Evolving European guidance on the medical management of neovascular age related macular degeneration
U. Chakravarthy et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?
CG Owen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Barriers to incident reporting in a healthcare system
R Lawton et al.
QUALITY & SAFETY IN HEALTH CARE (2002)
Share Paper
